Animal Antibiotics and Antimicrobials Market | Key Players are Zoetis, Inc., Merck & Co., Inc., Eli Lilly and Company, Bayer AG, Virbac, Boehringer Ingelheim GmbH, Sanofi, Ceva Sante Animale, Vetoquinol S.A., and Dechra Pharmaceuticals PLC.

According to the new market research report "Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone) Mode of Delivery (Premixes, Oral Powder, Injection) Animal (Food-producing & Companion) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Don’t miss out on business opportunities in Animal Antibiotics and Antimicrobials Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=25161353&utm_source=Openpr&utm_medium=Paid

Factors such as increasing animal population, rising demand for animal-derived food products, increasing incidences of zoonotic diseases, implementation of regulations for preventing the spread of animal diseases, and rising demand for pet insurance and growing animal health expenditure are the major factors driving the growth of the global animal antibiotics and antimicrobials market. However, dearth of new antibiotics, growing resistance to antimicrobials and antibiotics, and replacement of routine prophylactic use of antibiotics by good husbandry and hygiene practices may hinder the growth of this market to certain extent.

In this report, the animal antibiotics and antimicrobials market are segmented on the basis of product, mode of delivery, animal type, and region. Based on product, the market is segmented into tetracyclines, penicillins, macrolides, aminoglycosides, sulfonamides, fluoroquinolones, lincosamides, cephalosporins, and other antimicrobials and antibiotics. The tetracyclines accounted for the largest share of the animal antibiotics and antimicrobials market in 2015, owing to its wide utilization in food-producing animals. Based on mode of delivery, this market is further segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. Similarly, on the basis of type of animals the animal antibiotics and antimicrobials market are segmented into food-producing animals and companion animals.

Browse and in-depth TOC on " Animal Antibiotics and Antimicrobials Market "
165 – Tables
39 - Figures
207 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/animal-antimicrobials-antibiotics-market-25161353.html?utm_source=Openpr&utm_medium=Paid

The report analyzes the animal antibiotics and antimicrobials market by product, mode of delivery, animal type, and region. On the basis of products, the global animal antibiotics and antimicrobials market is further segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antibiotics and antimicrobials. Based on the various modes of delivery, the market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. On the basis of animal type, the global animal antibiotics and antimicrobials market is segmented into food-producing animals and companion animals.

In 2015, North America dominated the animal antibiotics and antimicrobials market followed by Europe, Asia-pacific, and Rest of the World. Increasing demand for animal-derived food products, rising companion animal healthcare expenditure, growing number of food-producing animals, and rising awareness about zoonotic diseases are factors driving the growth of this market. On the other hand, the Asia-Pacific (APAC) region is expected to witness the highest growth rate during the forecast period. This can be mainly attributed to the growing livestock population, increasing pet adoption, rising awareness about animal health, progressive urbanization, changing dietary habits, and growing per capita animal health expenditure in this region.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=25161353&utm_source=Openpr&utm_medium=Paid

Geographically, the global animal antibiotics and antimicrobials market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the animal antibiotics and antimicrobials market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to rising animal population, increase in the demand for animal-derived food products, growing per capita animal health expenditure, especially in India and China, and rising awareness regarding animal health and welfare.

Key Players:
Some of the prominent players in the animal antibiotics and antimicrobials market include Zoetis, Inc. (U.S.), Merck & Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Bayer AG (Germany), Virbac (France), Boehringer Ingelheim GmbH (Germany), Sanofi (France), Ceva Sante Animale (France), Vetoquinol S.A. (France), and Dechra Pharmaceuticals PLC (U.K.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact Us:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

This release was published on openPR.